Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset—Lessons Learned
Dölken, L.; Stich, A.; Spinner, C.D. Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset—Lessons Learned. Viruses 2021, 13, 963. https://doi.org/10.3390/v13060963
Dölken L, Stich A, Spinner CD. Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset—Lessons Learned. Viruses. 2021; 13(6):963. https://doi.org/10.3390/v13060963
Chicago/Turabian StyleDölken, Lars, August Stich, and Christoph D. Spinner. 2021. "Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset—Lessons Learned" Viruses 13, no. 6: 963. https://doi.org/10.3390/v13060963